化合物Piclozotan T28414

Product Introduction
Bioactivity


英文名: Piclozotan

描述: Piclozotan (anhydrous) 是一种 5-HT1A 受体激动剂，在短暂的大脑中动脉闭塞（t-MCAO）模型中表现出显着的神经保护活性,可以改善晚期帕金森病患者的运动并发症。

体内活性: Piclozotan (SUN N4057) (0.018 and 0.036 mg/kg/h; continuous subcutaneous infusion; 3 to 4 weeks; Parkinsonian rats) significantly lengthened the duration of rotational behavior by 26% and attenuated the increase in striatal levodopa-derived extracellular dopamine levels compared with the control group. Piclozotan (0.018 and 0.036 mg/kg/h, plasma concentrations 5.3±0.7 and 14.3±2.9 ng/ml) reduced levodopa-induced forelimb hyperkinesia by 55% and 69%, respectively, at 1h relative to the control.[1]

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

关键字: SUN-N4057 | SUN 4057 | SUNN 4057 | SUN-N 4057 | Piclozotan

相关产品: Palonosetron hydrochloride | Harmine | Methiothepin maleate | Nuciferine | Temanogrel | Litoxetine HCl | SB 243213 dihydrochloride | Aripiprazole Lauroxil | Binospirone | Cariprazine hydrochloride

化合物Piclozotan T28414信息由TargetMol中国为您提供，如您想了解更多关于化合物Piclozotan T28414报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途